Co-Diagnostics, Inc. Breakthrough CoPrimer™ Technology to be Featured at PAG XXVIII
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: Business Wire
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that the Company’s groundbreaking Co-Diagnostics CoPrimer™ technology will be featured at the International Plant & Animal Genome XXVIII conference, held on January 11-15 in San Diego, CA.The evaluation of BHQplex™ CoPrimers in flexible PCR-based genotyping will be presented by a representative of Bayer - Crop Science on Monday, January 13, in a presentation titled “CoPrimer Assays for Multiplex PCR.” According to the presentation abstract, Bayer evaluated the patented technology’s ability to enable robust and flexible multiplexing for PCR-based genotyping in several assays. This included successfully testing their performance in many different combinations and plex-levels using qPCR, end-point and digital PCR. BHQplex CoPrimers utilize the Company’s patented CoPrimer technology as branded by
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote AddressPR Newswire
- Global Covid-19 Diagnostic Market Analysis Report 2024: A New Large and Sustainable Market for Covid Related Diagnostics is Emerging [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, EnglandPR Newswire
CODX
Earnings
- 11/9/23 - Beat
CODX
Sec Filings
- 3/20/24 - Form 3
- 3/15/24 - Form 8-K
- 3/14/24 - Form 10-K
- CODX's page on the SEC website